Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Jul 19;11(14):e025657.
doi: 10.1161/JAHA.122.025657. Epub 2022 Jul 5.

Effect of Incorporating 1 Avocado Per Day Versus Habitual Diet on Visceral Adiposity: A Randomized Trial

Affiliations
Randomized Controlled Trial

Effect of Incorporating 1 Avocado Per Day Versus Habitual Diet on Visceral Adiposity: A Randomized Trial

Alice H Lichtenstein et al. J Am Heart Assoc. .

Abstract

Background Excess visceral adiposity is associated with increased risk of cardiometabolic disorders. Short-term well-controlled clinical trials suggest that regular avocado consumption favorably affects body weight, visceral adiposity, and satiety. Methods and Results The HAT Trial (Habitual Diet and Avocado Trial) was a multicenter, randomized, controlled parallel-arm trial designed to test whether consuming 1 large avocado per day for 6 months in a diverse group of free-living individuals (N=1008) with an elevated waist circumference compared with a habitual diet would decrease visceral adiposity as measured by magnetic resonance imaging. Secondary and additional end points related to risk factors associated with cardiometabolic disorders were assessed. The primary outcome, change in visceral adipose tissue volume during the intervention period, was not significantly different between the Avocado Supplemented and Habitual Diet Groups (estimated mean difference (0.017 L [-0.024 L, 0.058 L], P=0.405). No significant group differences were observed for the secondary outcomes of hepatic fat fraction, hsCRP (high-sensitivity C-reactive protein), and components of the metabolic syndrome. Of the additional outcome measures, modest but nominally significant reductions in total and low-density lipoprotein cholesterol were observed in the Avocado Supplemented compared with the Habitual Diet Group. Changes in the other additional and post hoc measures (body weight, body mass index, insulin, very low-density lipoprotein concentrations, and total cholesterol:high-density lipoprotein cholesterol ratio) were similar between the 2 groups. Conclusions Addition of 1 avocado per day to the habitual diet for 6 months in free-living individuals with elevated waist circumference did not reduce visceral adipose tissue volume and had minimal effect on risk factors associated with cardiometabolic disorders. Registration URL: https://clinicaltrials.gov; Unique identifier: NCT03528031.

Keywords: avocado; habitual diet; randomized clinical trial; risk factors for cardiometabolic disorders; visceral fat.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Consolidated Standards of Reporting Trials (CONSORT) diagram.
MRI indicates magnetic resonance imaging.
Figure 2
Figure 2. Visceral adipose tissue by subgroup.
For each subgroup, the estimated difference of the 6‐month effects on VAT between the Avocado Supplemented Diet group and the Habitual Diet group is shown as a solid square with a horizontal line showing its 95% CI. At the right, the estimated 6‐month effect on VAT from the mixed effects model is shown for each group along with a P value for the interaction terms, except for Overall, which is the P value for the difference. HEI indicates Healthy Eating Index (range from 0 to 100); Kcal, kilocalories; NonH White, Non‐Hispanic White; and VAT, visceral adipose tissue volume (in liters).

References

    1. Kim D, Hou W, Wang F, Arcan C. Factors affecting obesity and waist circumference among US adults. Prev Chronic Dis. 2019;16:E02. doi: 10.5888/pcd16.180220 - DOI - PMC - PubMed
    1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752. doi: 10.1161/CIRCULATIONAHA.105.169404 - DOI - PubMed
    1. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all‐cause, cardiovascular, and cancer mortality: sixteen years of follow‐up in US women. Circulation. 2008;117:1658–1667. doi: 10.1161/CIRCULATIONAHA.107.739714 - DOI - PubMed
    1. Song X, Jousilahti P, Stehouwer CD, Söderberg S, Onat A, Laatikainen T, Yudkin JS, Dankner R, Morris R, Tuomilehto J, et al. Comparison of various surrogate obesity indicators as predictors of cardiovascular mortality in four European populations. Eur J Clin Nutr. 2013;67:1298–1302. doi: 10.1038/ejcn.2013.203 - DOI - PubMed
    1. Lassale C, Tzoulaki I, Moons KGM, Sweeting M, Boer J, Johnson L, Huerta JM, Agnoli C, Freisling H, Weiderpass E, et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan‐European case‐cohort analysis. Eur Heart J. 2018;39:397–406. doi: 10.1093/eurheartj/ehx448 - DOI - PMC - PubMed

Publication types

Associated data